Tabimorelin
Tabimorelin (NN703) is an orally active growth hormone (GH) secretagogue. Tabimorelin is also a potent inhibitor of CYP3A4 activity[1].
Product Specifications
CAS Number
[193079-69-5]
Product Name Alternative
NN703
UNSPSC
12352005
Target
Cytochrome P450
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Endocrinology
Assay Protocol
https://www.medchemexpress.com/tabimorelin.html
Purity
98.11
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
CC(N)(C/C=C/C(N([C@H](CC1=CC=C2C=CC=CC2=C1)C(N([C@H](CC3=CC=CC=C3)C(NC)=O)C)=O)C)=O)C
Molecular Formula
C32H40N4O3
Molecular Weight
528.69
References & Citations
[1]Zdravkovic M, et al. A clinical study investigating the pharmacokinetic interaction between NN703 (tabimorelin), a potential inhibitor of CYP3A4 activity, and midazolam, a CYP3A4 substrate. Eur J Clin Pharmacol. 2003 Feb;58 (10) :683-8.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
CYP3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6342739-01 0.1 mL
RNF180, CT (RNF180, E3 ubiquitin-protein ligase RNF180, RING finger protein 180) (MaxLight 650)
Ask
View Details MBS6342739-02 5x 0.1 mL
RNF180, CT (RNF180, E3 ubiquitin-protein ligase RNF180, RING finger protein 180) (MaxLight 650)
Ask
View Details